(Q45880368)

English

High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

phase I clinical trial

0 references

coronary artery disease

1 reference

based on heuristic

inferred from title

Liliana Favaloro

1

object named as

Liliana Favaloro

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

author name string

Mirta Diez

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Oscar Mendiz

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Gustavo Vera Janavel

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

León Valdivieso

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Roxana Ratto

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Guillermo Garelli

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Fabián Salmo

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Marcelo Criscuolo

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Andrés Bercovich

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Alberto Crottogini

11

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

publication date

5 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Catheterization and Cardiovascular Interventions

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

82

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

899-906

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Arteriogenesis Induced by Intramyocardial Vascular Endothelial Growth Factor 165 Gene Transfer in Chronically Ischemic Pigs

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Monitoring the quality of life in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials

1 reference

https://api.crossref.org/works/10.1002%2FCCD.24555

21 January 2018

Identifiers

10.1002/CCD.24555

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/22777825

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45880368&oldid=2088312801"